AI Training Use and Ownership of Vectorized Model Data

What it is

The terms authorize Oscar to use de-identified and anonymized User Submissions to train, optimize, and enhance its AI systems. Oscar asserts ownership of any vectorized data or model relationship information derived from User Submissions and used in AI training.

Why it matters (compliance & governance perspective)

This provision asserts that Oscar owns derivative AI assets, specifically vectorized data and model relationship information, developed from User Submissions. This assertion of ownership over AI-derived data may intersect with user data rights under applicable privacy law and warrants legal assessment of whether the de-identification standard applied satisfies applicable requirements.

Consumer impact (what this means for users)

Under this clause, content users submit through the Services may be used in de-identified form to train Oscar's AI systems, and Oscar asserts ownership of any resulting vectorized or model-derived data. The agreement characterizes this use as falling within the broader license granted over User Submissions rather than as a separate consent mechanism.

Institutional analysis (regulatory & governance intelligence)

1. REGULATORY LANDSCAPE: This provision engages HIPAA where User Submissions include or are derived from protected health information, as de-identification standards under HIPAA are specific and technical. HHS OCR is the primary enforcement authority. State health data privacy laws, including those in states that have enacted standalone health data statutes beyond HIPAA, may impose additional requirements on the use of health-related user data for AI training. The FTC's Health Breach Notification Rule and emerging state AI governance frameworks may also be relevant. 2. GOVERNANCE EXPOSURE: High. The assertion that Oscar owns vectorized data and model relationship information derived from User Submissions is a materially significant IP claim. The adequacy of the de-identification and anonymization process is not defined in the document, creating ambiguity about whether the standard applied satisfies HIPAA Safe Harbor or Expert Determination requirements. If health-related data is not properly de-identified, use for AI training may raise HIPAA compliance questions. 3. JURISDICTION FLAGS: States with standalone consumer health data privacy statutes, such as Washington State's My Health MY Data Act, may impose consent or use restrictions on health-related data used for AI training that go beyond HIPAA requirements. EU or EEA users, if any, would trigger GDPR considerations regarding lawful basis for processing and automated decision-making, though the document does not address a non-US user population explicitly. 4. CONTRACT AND VENDOR IMPLICATIONS: The document does not specify the de-identification methodology applied before AI training use, which creates a gap for vendor and partner due diligence where downstream AI outputs are shared or licensed. Legal teams should assess whether sublicensing of the User Submission license to AI infrastructure vendors is addressed in applicable data processing agreements. 5. COMPLIANCE CONSIDERATIONS: Compliance teams should evaluate whether the consent mechanism embedded in these Terms satisfies applicable requirements for use of health-adjacent user data in AI training, including any state-specific opt-in requirements. Data mapping should be updated to reflect this AI training use pathway. The adequacy of de-identification processes should be documented and reviewed against HIPAA standards and applicable state law.

Applicable agencies

Provision details

Other risks in this policy

• Class actions and class arbitrations prohibited high
• Health content is informational only not medical advice high
• Oscar granted perpetual license to User Submissions high
• Oscar liability cap at fees paid or $100 high
• Oscar may suspend discontinue or restrict Services high
• Oscar may terminate user access for any reason high